Cleared Traditional

K180175 - SignalMark Lung Biopsy Site Marker

K180175 is an FDA 510(k) clearance for SignalMark Lung Biopsy Site Marker, manufactured by View Point Medical, Inc.. The device is a Class 2 General & Plastic Surgery device with product code GDW cleared through the Traditional 510(k) pathway after a 319-day FDA review.

K180175 · View Point Medical, Inc. · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2018
Decision
319d
Days
Class 2
Risk

K180175 is an FDA 510(k) clearance for the SignalMark Lung Biopsy Site Marker. Classified as Staple, Implantable (product code GDW), Class II - Special Controls.

Submitted by View Point Medical, Inc. (San Clemente, US). The FDA issued a Cleared decision on December 7, 2018 after a review of 319 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4750 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.

View all View Point Medical, Inc. devices

FDA 510(k) Submission Details - K180175

510(k) Number K180175 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 22, 2018
Decision Date December 07, 2018
Days to Decision 319 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
204d slower than avg
Panel avg: 115d · This submission: 319d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GDW Device Classification - Class 2, Special Controls

Product Code GDW Staple, Implantable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4750
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - GDW Staple, Implantable

All 240
Devices cleared under the same product code (GDW) and FDA review panel - the closest regulatory comparables to K180175.
easyPPHTM Hemorrhoidal Stapler for Single Use
K183477 · Ezisurg Medical Co., Ltd. · Feb 2019
Echelon Endoscopic Linear Cutter Reloads, White, Blue, Gold, Green and Black
K183435 · Ethicon Endo-Surgery, LLC · Feb 2019
easyLCTM Linear Cutter Staplers and Loading Units fot Single Use
K181657 · Ezisurg Medical Co., Ltd. · Feb 2019
AEON Endoscopic Stapler
K182380 · Lexington Medical, Inc. · Nov 2018
Endoscopic Linear Cutting Staplers and Loading Units for Single Use
K181620 · Ezisurg (Suzhou) Medical Co., Ltd. · Sep 2018
Ethicon Circular Stapler, Ethicon Circular Stapler -XL Sealed
K181653 · Ethicon Endo-Surgery, LLC · Sep 2018